Immune checkpoint markers are expressed on immune cells (i.e. PD-1, CTLA-4, CD25) and on tumor cells (PD-L1) and together inhibit immune cell activation and elimination of tumor cells12,13. The gene discussed is CTLA4; the disease is neoplasm.